We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Nuevolution Announces Collaboration in Drug Discovery with Boehringer Ingelheim

News   Sep 21, 2011

 
Nuevolution Announces Collaboration in Drug Discovery with Boehringer Ingelheim
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

News

The World Health Organization (WHO) has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue hydroxychloroquine and lopinavir/ritonavir study arms.

READ MORE

Asthma Drug Salbutamol Inhibits Tau Filament Formation In Vitro

News

A new study suggests that the common asthma drug called salbutamol may offer potential as a treatment for Alzheimer’s disease. Extensive analytical in vitro experiments show that salbutamol is effective at reducing the accumulation of insoluble fibres of the tau protein – which is found in the brains of people with Alzheimer’s disease.

READ MORE

Novel Strategy Generates Useful Compounds for Drug Synthesis

News

A team of scientists has designed a novel catalytic method that can generate useful chiral compounds. This new strategy could provide an effective synthetic way to design pharmaceutical products.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE